Hepatocellular damage by cyproterone acetate.
暂无分享，去创建一个
[1] W. Sluiter,et al. Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients , 2004, Cancer Chemotherapy and Pharmacology.
[2] Shah Ss,et al. The cytarabine syndrome in an adult. , 1983 .
[3] P. Rosen,et al. Tamoxifen flare in advanced breast cancer. , 1978, JAMA.
[4] Bender Ad,et al. Pharmacokinetic Consequences of Aging , 1977 .
[5] F. Neumann. Pharmacology and Potential Use of Cyproterone Acetate* , 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[6] I. Leo-Rossberg,et al. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. , 1975, Journal of steroid biochemistry.
[7] U. Laschet,et al. Psychopharmacotherapy of Sex Offenders with Cyproterone Acetate , 1971 .
[8] F. Ott,et al. [Influence of antiandrogens on libido, potency and testicular function]. , 1968, Schweizerische medizinische Wochenschrift.
[9] G. Routier,et al. Hepatite severe et progestatifs de synthèse. , 1967 .
[10] P. Hartley,et al. Factors affecting the response of immunized guinea pigs to antigenic stimulus; further observations. , 1949, Lancet.